References
1. Lloyd RV, et. al. Science, 1983, 222:628–30. 2. Riddell K, et. al. Lab Invest 56:64A, 1987|Additional: 1. Battersby S; Dely CJ; Hopkinson HE; Anderson TJ. The nature of breast dense core granules: chromogranin reactivity. Histopathology, 1992, 20:107–14. 2. Lukinius A; Wilander E; Eriksson B; Oberg K. A chromogranin peptide is co-stored with insulin in the human pancreatic islet B-cell granules. Histochemical Journal, 1992 Sep, 24(9):679–84. 3. Wirnsberger GH; Becker H; Ziervogel K; Hofler H. Diagnostic immunohistochemistry of neuroblastic tumors. Am J of Surgical Pathology, 1992, 16:49–57. 4. Diepholder HM; Schwechheimer K; Mohadjer M; Knoth R; Volk B. A clinicopathologic and immunomorphologic study of 13 cases of ganglioglioma. Cancer, 1991, 68(10):2192- 201. 5. Kalina M; Grimelius L. Chromogranins or chromograninlike proteins are present in lamellar bodies and pulmonary surfactant of rat alveolar type II cells. Journal of Histochemistry and Cytochemistry, 1991 Feb, 39(2):213–20. 6. Munoz DG. Chromogranin A-like immunoreactive neurites are major constituents of senile plaques. Lab Investigation, 1991, 64:826–32. 7. Weihe E; Horsch D; Eiden LE; Hartschuh W. Dual presence of chromogranin A-like immunoreactivity in a population of endocrine-like cells and in nerve fibers in the human anal canal. Neuroscience Letters, 1991 Sep 16, 130(2):190–4. 8. Andreola S; Lombardi L; Audisio RA; Mazzaferro V; Koukouras D; Doci R; Gennari L; Makowka L; Starzl TE; van Thiel DH. A clinicopathologic study of primary hepatic carcinoid tumors. Cancer, 1990 Mar 1, 65(5):1211–8. 9. Becker H; Wirnsberger G; Ziervogel K; Hofler H. Immunohistochemical markers in (ganglio)neuroblastomas. Acta Histochemica. Supplementband, 1990, 38:107–14. 10. McAuliffe WG; Hess A. Human chromogranin A-like immunoreactivity in the Bergmann glia of the rat brain. Glia, 1990, 3(1):13–6. 11. Munoz DG; Kobylinski L; Henry DD; George DH. Chromogranin A-like immunoreactivity in the human brain: distribution in bulbar medulla and cerebral cortex. Neuroscience, 1990, 34(3):533–43. 12. Chang TK; Li CY; Smithson WA. Immunocytochemical study of small round cell tumors in routinely processed specimens. Archives of Pathol and Lab Medicine, 1989, 113:1343–8. 13. Hawkins KL; Lloyd RV; Toy KA. Immunohistochemical localization of chromogranin A in normal tissues from laboratory animals. Veterinary Pathology, 1989 Nov, 26(6):488–98. 14. Lloyd RV; Iacangelo A; Eiden LE; Cano M; Jin L; Grimes M. Chromogranin A and B messenger ribonucleic acids in pituitary and other normal and neoplastic human endocrine tissues. Laboratory Investigation, 1989 Apr, 60(4):548–56. 15. Hearn SA. Electron microscopic localization of chromogranin A in osmium-fixed neuroendocrine cells with a protein A-gold technique. Journal of Histochemistry and Cytochem, 1987, 35:795–801. 16. Wahl RL; Wilson BS; Liebert M; Beierwaltes WH. Highdose, unlabeled, nonspecific antibody pretreatment: influence on specific antibody localization to human melanoma xenografts. Cancer Immunology, Immunotherapy, 1987, 24(3):221–4. 17. Aguirre P; Scully RE; Wolfe HJ; DeLellis RA. Argyrophil cells in Brenner tumors: histochemical and immunohistochemical analysis. Int Journal of Gynecological Pathology, 1986, 5(3):223–34. 18. Wilson BS; Phan SH; Lloyd RV. Chromogranin from normal human adrenal glands: purification by monoclonal antibody affinity chromatography and partial N-terminal amino acid sequence. Regulatory Peptides, 1986 Feb, 13(3–4):207–23. 19. Bussolati G; Gugliotta P; Sapino A; Eusebi V; Lloyd RV. Chromogranin-reactive endocrine cells in argyrophilic carcinomas (“carcinoids”) and normal tissue of the breast. Am J of Pathol, 1985, 120:186–92. 20. Varndell IM; Lloyd RV; Wilson BS; Polak JM. Ultrastructural localization of chromogranin: a potential marker for the electron microscopical recognition of endocrine cell secretory granules. Histochemical Journal, 1985 Sep, 17(9):981–92. 21. DeStephano DB; Lloyd RV; Pike AM; Wilson BS. Pituitary adenomas. An immunohistochemical study of hormone production and chromogranin localization. American Journal of Pathology, 1984 Sep, 116(3):464–72. 22. Wilson BS; Lloyd RV. Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. American Journal of Pathology, 1984 Jun, 115(3):458–68. 23. Lloyd RV; Wilson BS. Specific endocrine tissue marker defined by a monoclonal antibody. Science, 1983 Nov 11, 222(4624):628–30. 24. Dottorini ME; Assi A; Sironi M; Sangalli G; Spreafico G; Colombo L. Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables. Cancer, 1996 Apr 15, 77(8):1556–65. 25. Bjerkehagen B; Fossa SD; Raabe N; Holm R; Nesland JM. Transitional cell carcinoma of the renal pelvis and its expression of p53 protein, c-erbB-2 protein, neuron-specific enolase, Phe 5, chromo-granin, laminin and collagen type IV. European Urology, 1994, 26(4):334–9. 26. Haddad MG; Silverman JF. Fine-needle aspiration cytology of metastatic basal cell carcinoma of the skin to the lung. Diagnostic Cytopathology, 1994, 10(1):15–9. 27. Munoz DG. Chromogranin A-like immuno-reactive neurites are major constituents of senile plaques. Laboratory Investigation, 1991, 64:826–32.USBio References
No references available
TDS
NCBI
UniProt
Tech Support
Customer Service
